Neurobehavioral Differences of Valproate and Risperidone on MK-801 Inducing Acute Hyperlocomotion in Mice
Behavioural Neurology · 23.02.2022 · 2022 · 1-12
DOI: 10.1155/2022/1048463 ↗Kurz gefasst
Fachartikel in der Zeitschrift Behavioural Neurology, erschienen am 23.02.2022. Verfasst von Po-An Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan. Hauptthemen laut MEDLINE: Dizocilpine Maleate, Risperidone, Valproic Acid. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taipei Tzu Chi Hospital, Ministry of Science and Technology.
Abstract (Originalsprache)
Objective
The glutamate system plays a major role in the development of neuropsychiatric disorders such as addiction, epilepsy, dementia, and psychosis. MK-801 (dizocilpine), an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, could increase locomotor activity and stereotyped neurobehaviors mimicking schizophrenic-like features in the mouse model. The study would explore the neuropharmacological differences of risperidone and valproic acid on the MK-801-induced neurobehavioral changes.
Methods
The subjects were male C57BL/6J mice obtained from the National Laboratory Animal Center. Drug effects were assessed using the open field with a video-tracking system and gaiting tests. After habitation, risperidone (0, 0.1 mg/kg) or valproic acid (0, 200 mg/kg) was injected and ran locomotion for 30 mins. Sequentially, mice were followed by intraperitoneal injection (i.p.) with MK-801 (0, 0.2 mg/kg) and ran locomotion for 60 mins. Gaiting behaviors such as step angles, stride lengths, and stance widths were measured following the study drugs.
Results
The results showed that risperidone and valproic acid alone could not alter the locomotor activities. Following the MK-801 injection, the travelled distance and speed in the entire open field dramatically increased. The dose 0.1 mg/kg of risperidone could totally inhibit the MK-801-induced hyperlocomotion compared with that of the saline-injected group ( p < 0.001 ). The valproic acid (200 mg/kg) partially suppressed the hyperlocomotion which is induced by MK801.
Conclusion
The more dominant effect of risperidone to rescue MK-801 induced hyperlocomotion compared with that of valproic acid. The partial suppression of valproic acid may imply the psychopharmacological evidence as adjuvant effect to treat psychotic patients through tuning glutamatergic neurotransmission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
- Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
- Department of Psychiatry, School of Medicine, Tzu Chi University, Hualien, Taiwan.
ORCID-Profile: Mao-Liang Chen, Yi-Chyan Chen
Förderung
- Taipei Tzu Chi Hospital
- Ministry of Science and Technology
Zitieren
APA
Chen, P. A., Wang, H. Y., Sun, C. L., Chen, M. L., & Chen, Y. C. (2022). Neurobehavioral Differences of Valproate and Risperidone on MK-801 Inducing Acute Hyperlocomotion in Mice. Behavioural Neurology, 2022, 1-12. https://doi.org/10.1155/2022/1048463
Vancouver
Chen PA, Wang HY, Sun CL, Chen ML, Chen YC. Neurobehavioral Differences of Valproate and Risperidone on MK-801 Inducing Acute Hyperlocomotion in Mice. Behavioural Neurology. 2022;2022:1-12. doi:10.1155/2022/1048463
BibTeX
@article{Chen2022,
author = {Chen, Po-An and Wang, Hui-Yi and Sun, Chien-Lun and Chen, Mao-Liang and Chen, Yi-Chyan},
title = {Neurobehavioral Differences of Valproate and Risperidone on MK-801 Inducing Acute Hyperlocomotion in Mice},
journal = {Behavioural Neurology},
year = {2022},
volume = {2022},
pages = {1--12},
doi = {10.1155/2022/1048463}
}
EUVIMED